跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
蔡 曜聲
教授
臨床醫學研究所
電子郵件
yaustsai
mail.ncku.edu
tw
h-index
2820
引文
26
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1998 …
2025
每年研究成果
概覽
指紋
網路
專案
(21)
研究成果
(85)
類似的個人檔案
(6)
監製作品
(6)
指紋
查看啟用 Yau-Sheng Tsai 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Biochemistry, Genetics and Molecular Biology
Peroxisome Proliferator-Activated Receptor
100%
Insulin Resistance
62%
Adipocyte
40%
Fibrinogen
34%
Thiazolidinedione
34%
Skeletal Muscle
34%
Insulin Sensitivity
33%
Mitochondrial Dynamics
27%
C2C12
23%
Blood Pressure
23%
Mitochondrial Fission
22%
Hyperglycemia
20%
Adipokine
20%
Allele
20%
Prevalence
19%
Glucose Homeostasis
19%
Messenger RNA
18%
Arterial Stiffness
17%
Genetic Variation
17%
C-Terminus
17%
Early Growth Response Factor 1
17%
Human immunodeficiency virus
17%
Impaired Glucose Tolerance
17%
Environmental Temperature
17%
Cytokine Production
17%
Akita Mouse
17%
Hemodialysis
17%
Thermogenesis
17%
Melanocortin 4 Receptor
17%
INSIG2
17%
Body Fat Distribution
17%
Epigenetics
17%
Body Fat
17%
Mitochondrial Disorder
17%
Rosiglitazone
17%
Calcium ATPase
17%
P21
17%
Protein Kinase B
17%
Gene Cluster
17%
Dyslipidemia
17%
Myogenesis
17%
Embryonic Stem Cell
17%
P53
17%
Adiponectin
17%
Lysyl Oxidase
17%
Genetics
13%
Protein Expression
13%
APOA5
12%
Ob/Ob Mouse
11%
Insulin Blood Level
11%
Medicine and Dentistry
Arterial Stiffness
51%
Insulin Resistance
42%
Protein Kinase B
35%
Inflammasome
34%
Malignant Neoplasm
34%
Diseases
32%
Calcium Oxalate
31%
Insulin Sensitivity
30%
Maturity Onset Diabetes of the Young
25%
Nonalcoholic Fatty Liver
23%
Kidney Stone
22%
Diabetes Mellitus
21%
Toll Like Receptor 2
21%
High Fat Food
20%
Insulin Signaling
20%
Skeletal Muscle
20%
Infection
20%
Adipose Tissue
19%
Glucose Homeostasis
19%
Adipocyte
18%
Mitochondrial Disorder
17%
Peptoclostridium difficile
17%
Disease Exacerbation
17%
Osteopontin
17%
Mitochondrial Fission
17%
Impaired Glucose Tolerance
17%
Mesothelial Cell
17%
Glycogen Synthase Kinase 3
17%
Immunostimulation
17%
Early Growth Response Factor 1
17%
Hyperlipidemia
17%
Cystatin C
17%
Medicine
17%
Biomedical Discipline
17%
Hyperventilation
17%
Uremic Toxin
17%
Chronic Kidney Disease
17%
Oxidized Low Density Lipoprotein
17%
Morbid Obesity
17%
Sarcopenic Obesity
17%
Non-Alcoholic Fatty Liver Disease
17%
Melanocortin 4 Receptor
17%
Diabetic Wound
17%
Body Fat Distribution
17%
Cohort Analysis
17%
Mixed Infection
17%
Kidney Fibrosis
17%
Drug Resistance
17%
Hernia
17%
End Stage Renal Disease
17%
Keyphrases
Dialysis Disequilibrium Syndrome
17%
Arterial Stiffness
17%
Abnormal Fat Distribution
17%
Clostridioides Difficile
17%
Streptokinase
17%
Human Disease
17%
Renal Uptake
17%
Strain Resistance
17%
Beijing Strain
17%
Carboxyl
17%
Androgenetic Alopecia
17%
Medical Colleges
17%
Apologizing
17%
Metabolic Healthy
17%
Adipocyte Differentiation
17%
In Cancer
17%
Reactive Oxygen Species
17%
Inflammasome Activation
17%
Anti-hepatitis C Virus
17%
Mesothelial Cells
17%
Short Daily
17%
Epithelial-to-mesenchymal Transition
17%
High Risk
17%
Metabolically Abnormal Obesity
17%
Storage Dysfunction
17%
Signaling Axis
17%
Insulin Storage
17%
Female Mice
17%
Akita
17%
Tubular Inflammation
17%
Hepatic Insulin Signaling
17%
Ins2
17%
Arteriovenous Access
17%
Vascular Dysfunction
17%
Vascular Hypertrophy
17%
Insulin
17%
Cerebral Arterioles
17%
Scl1
17%
Phosphorylation
17%
Serum Leptin
17%
Metabolically Healthy Obesity
17%
Diabetic Wound Healing
17%
Hydrometry
17%
Related Traits
17%
INSIG2
17%
Fluoxetine
17%
Collagen-like
17%
Body Fat Distribution
17%
Morbid Obesity
17%
Melanocortin 4 Receptor (MC4R)
17%
